this link is to an external site that may or may not meet accessibility guidelines.
Thembinkosi Lorch (Backpagemedia)
Orlando Pirates have confirmed that both Justin Shonga and Thembinkosi Lorch were dropped from their squad “following a breach of the team’s protocols.”
Pirates are in action on Tuesday evening against Mamelodi Sundowns as the ABSA Premiership gets underway for the first time since March.
“All players have been educated, and are constantly reminded, of their responsibilities as public servants and role models,” said a statement released on the club website.
“It is our role and duty to ensure that all members of this organisation are fully compliant and aware of the measures that are in place.
“Both players will be afforded the opportunity to return to play once the disciplinary processes have been finalised.
“Mr Lorch and Mr Shonga will also be required to undergo two Covid-19 tests, which both must be negative, as the BSE protocols dictate, before they resume any club activities,” the statement concluded.
Pirates are currently third on the Absa Premiership log.
– Compiled by Sport24 staff
A manufacturing concern is seeking a General Practitioner (Doctor) – Occupational Medical Practitioner for the Provision of Occupational and Primary Healthcare services. The successful candidate will be reporting to the Manager Corporate Health Services, who will remain responsible for the corporate health strategy and developing occupational health initiatives.
Open position : General Practitioner (Doctor)
Location : Port Elizabeth
Salary : Market related
Type : 1 year contract
Criteria (Qualification/Experience/Skills) • MB, ChB
• Diploma in Occupational Health
• Registration with Health Professional Council of SA
• Minimum of 2 years’ experience as General Practitioner
• Previous experience in Occupational Medicine of at least 2 years
• Basic Life Support / ACLS / ATLS – highly advantageous
• Dispensing Course & License
• Short course: Audiometry, Spirometry & Vision Screening
• Strong interpersonal relationships
• Ability to interface and communicate with all levels of staff including Top Management and the Union
• Conflict Management and negotiation skills
• Training skills
• Analytical skills
• Business/Financial acumen
• Decision-making skills
• Project management skills
• Administration skills
• Computer literacy
Functions of the job :
• Liaise and engage with OHSE (Safety department) regarding Risk Assessments and Occupational Hygiene surveys
• Assess and determine all Injuries on Duty, apply the necessary treatment and document the information as required by the Compensation for Occupational Injuries and Diseases Act
• Assess and determine all medical emergencies which arise in the Plant, initiate treatment and co-ordinate further treatment as required
• Determine, assess, analyse and advise the company on all Occupational Diseases and comply with the statutory requirements
• Co-ordinate the health programs of the organization viz TB, HIV, STI’s and Health Checks
• Co-ordinate the Medical Surveillance program eg statutory apprentice medicals, audiometry, lung function, vision screening, driver medicals, lead handlers, spray painters, radiation workers, food handlers and quality inspector medicals
• Assess, advise and approve all pre-employment / pre-placement, periodic, transfer medical examinations
• Co-ordinate the provision of Exit medicals
• Co-ordinate Disability Management
• Facilitate referral to Employee Assistance Programmes (EAP)
• Oversee the procurement of medical supplies as per the Pharmaceutical Act
• Monitor and evaluate Sick Absenteeism company-wide, approve sick leave and advise management
• Liaise and engage with local doctors, hospitals and other service providers
• Liaise and work with the local and national Department of Health
• Be aware and plan action for Infectious Disease outbreaks
• Training of Occupational Health Nursing Practitioners (OHNP)
Should you meet the above job requirements please email your CV to firstname.lastname@example.org
Please add the “General Practitioner (Doctor)” in the title of your email.
No reply after 2 weeks indicates that you have been unsuccessful
Lungisa Fuzile (Felix Dlangamandla)
- Former Treasury DG and Van Rooyen’s lawyer went back and forth over the appointment of the adviser and chief of staff.
- Fuzile and Van Rooyen have different versions of what took place at the swearing-in at Union Buildings in 2015.
- Fuzile believes Van Rooyen’s lawyer did not deal with the material issue during cross-examination.
Former Treasury director-general (DG) Lungisa Fuzile and Des van Rooyen’s lawyer engaged in a tense exchange over the irregular appointments of two advisers during the former finance minister’s infamous “weekend appointment” in December 2015.
This comes after Van Rooyen’s lawyer, advocate Kgomosoane Mathipa, raised the appointment of Mohamed Bobat as the minister’s adviser and Ian Whitley as his chief of staff.
Mathipa put it to Fuzile that Bobat was first introduced to him by Van Rooyen as his special advisor, during Van Rooyen’s swearing-in ceremony at the Union Buildings. Van Rooyen then asked Fuzile to “expedite” Bobat’s appointment, the commission heard on Tuesday.
Fuzile responded, saying this was not true and that it was Bobat who introduced himself, not Van Rooyen.
“I found him there, I got the impression that they did not know each other,” Fuzile said.
Mathipa said his client believed he had introduced the two, after the swearing-in ceremony.
“I deny that,” Fuzile said in response.
Mathipa then put to Fuzile that he had not told the truth around the matter of Van Rooyen confusing the roles of the two men in his office.
“Mr Fuzile [in your statement] you say, ‘Mr Van Rooyen instructed me to expedite the process of formalising the appointment of Mr Mohamed Bobat and Mr Ian Whitley as advisor and chief of staff respectively’.
“But the difference, though, is that when you went to testify at the commission, you then said he [Van Rooyen] confused their positions, in his very office.
“But in your statement, the only time you say that Mr Van Rooyen confused the positions of the two people was at the meeting with the executive management.”
Fuzile then responded to Mathipa, asking what his point was.
“You didn’t tell the commission the truth, that’s what I’m saying. Because he did not confuse them.”
Fuzile denied this and said what was important was the fact that due process hadn’t been followed in the appointments.
Fuzile responded saying:
No, I thought the most material thing you would have tried to deal with… is that he hadn’t followed due process to appoint them. That is the material thing, rather than he confused their names, to be honest with you.
Mathipa stood his ground, insisting Fuzile’s claims of Van Rooyen confusing the roles of both men was not true, and put it to him that he had lied to the commission.
Fuzile also dug in his heels, saying the fact that he only mentioned the ‘confusing’ once in his statement did not mean it had not happened on other occasions.
“He may have confused them again… and I may not have mentioned it in my statement. Does it make it a lie simply because I don’t repeat it?
“I deny that simply because I don’t repeat it, that he confused them, it makes it a lie.”
Mathipa then moved to a part in Fuzile’s statement, where he had said that, as a director-general, he regarded himself as the chief advisor to the minister of finance.
He put it to Fuzile that, at no stage, did he advise Van Rooyen he was not entitled to appoint Bobat and Whitley until the process was formalised.
“You never said that to him?” Mathipa asked.
“I did not know that the minister does not know that people do not work without a contract. Twice, I reminded them of the ministerial handbook and I went further to ask them to familiarise themselves with it.
“You don’t consider that to be advice to him in your world?” Fuzile said in response to the Mathipa’s question, which he described as “misplaced”.
The commission continues with Van Rooyen’s evidence.
Explainer: When will a Covid-19 vaccine be ready?
Around the world, politicians, drugmakers and regulators offer contradictory outlooks on when a Covid-19 vaccine will be ready. Much depends on what ‘ready’ means and for what group of people.
Some key questions around the timeline are:
When will we know a vaccine works? More than half a dozen drugmakers around the world are conducting advanced clinical trials, each with tens of thousands of participants, and several expect to know if their Covid-19 vaccines work and are safe by the end of this year.
The most optimistic timeline comes from AstraZeneca Plc, which is running a study in Britain that it says could be completed as early as August.
Dr Anthony Fauci, the top US infectious diseases expert, said last week that a trial by Moderna Inc could produce decisive results by November or December. Others will come later, some much later.
But some experts are skeptical that the trials, which must study potential side effects on different types of people, can be completed that quickly.
When will the first shots be ready? Several drugmakers are building manufacturing capacity so they can begin production as soon as vaccines are approved by regulators. Some efforts are backed by a US government program called ‘Operation Warp Speed’.
Fauci expects “tens of millions” of doses to be available in early 2021, and that by the end of the year there could be more than a billion.
Several companies say they each expect to make more than 1 billion doses next year. That could mean several billion available by the end of 2021.
When can I get it? First supplies late this year or early next would likely go to those in rich nations who are deemed by governments to work in essential industries or who are at greatest risk from the virus. That is likely to include people with other issues such as diabetes, healthcare workers, and members of the military.
Countries including Canada, Japan, Britain, and the United States have locked in deals putting their citizens first in line for inoculations as they become broadly available during 2021.
When will the world be inoculated? The wait time for Covid-19 vaccines will likely be longer for people in developing countries, which don’t have early supply deals. Some countries may struggle to pay for vaccines.
And what about Russia’s vaccine? Russia has become the first country in the world to grant regulatory approval to a Covid-19 vaccine after less than two months of human testing.
The vaccine still has to complete final trials, raising concerns among some experts at the speed of its approval. Still, Russian business conglomerate Sistema has said it expects to put it into mass production by the end of the year.